MedMisr
PrivateLast Round
Accelerator
May 14, 2018
Est. Valuation
$280,000
Total Funding Raised
$30,000
Company Overview
MedMisr operates in Healthcare & Life Sciences and is based in Cairo. Its latest recorded funding round was an Accelerator round in May 2018.
MedMisr is a health insurance technology company that provides a digital third-party administrator (TPA) platform for medical claims management.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, Revenue Cycle, Digital Payments
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedMisr Comparables
Compare MedMisr with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SehaTech | 87% | |
| Nice Deer | 86% | |
| GlobeMed Group | 78% |
For institutional investors. Book with your work email.
MedMisr Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
MedMisr Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flat6Labs | Accelerator |
MedMisr Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MedMisr's valuation, stock price, and market status.
Is MedMisr a public or private company?
MedMisr is a private company.
What is the current stock price of MedMisr?
MedMisr is a private company, so its shares have no public market price. Caplight tracks MedMisr's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedMisr worth (valuation)?
MedMisr's valuation is estimated at $280.0K based on funding round data.
Can I buy MedMisr stock?
MedMisr shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedMisr's last funding round?
MedMisr's most recent funding round was Accelerator on May 14, 2018.
Who are the main investors in MedMisr?
Key investors in MedMisr include Flat6Labs.
Will MedMisr IPO soon?
No public IPO plans have been announced for MedMisr.
How can I track MedMisr secondary market activity?
Caplight tracks bids, offers, and trades in MedMisr's shares on secondary markets.